Las Vegas, NV -- (SBWIRE) -- 11/20/2012 -- Amarantus Biosciences Inc. (OTC: AMBS) has made a big move in recent weeks from a start point of well under a penny to recent highs of $0.09 Currently trading at just over a nickel AMNS is on every speculators watch list.
Much of the recent increase in volume and price per share is due to the Cmpanany's Mesencephalic-Astrocyte-derived Neurotrophic Factor (MANF”). MANF is a protein that corrects protein misfolding. Protein misfolding is one of the major causes of apoptosis (cell death). This property provides a compelling rationale for the research and development of MANF-based products as therapeutics for human disease. Our lead MANF product development effort is centered on a therapy for Parkinson’s disease.
In a massive endorsement Amgen Co-Founder Joseph Rubinfeld, PhD joined the AMBS Corporate Advisory Board. “I believe in MANF,” said Dr. Rubinfeld, “I have reviewed a great number of technologies in my 45 year career in the biopharmaceutical field, and I believe that MANF could be one of the biggest successes that I have ever seen”
AMARANTUS BIOSCI INC(OTC:AMBS)recently announced that the Opposition Division of the European Patent Office upheld Amarantus Bioscience's European Patent relating to neurotrophic factor MANF, following opposition by rival Hermo Pharma OY of Finland.
For more information on Amarantus Biosciences Inc. please visit here: AMBS
AwesomePennyStocker is all about parabolic penny stocks that make epic moves up and reap massive gains for investors. Penny Stocks are heating up and APSR will reports on all of them letting investors know the difference between the winners and the losers. Come visit AwesomePennyStocker for yourself and see what everyone is talking about!
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PLEASE NOTE: awesomepennystocker.com employees are not registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at http://awesomepennystocker.com/disclaimer. Release of Liability: Through use of this website viewing or using you agree to hold awesomepennystocker.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss monetary or otherwise, damage monetary or otherwise, or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. awesomepennystocker.com affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. awesomepennystocker.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and awesomepennystocker.com. We make no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. This is not a solicitation to buy or sell any securities. Any claims or Statements should be deemed hypothetical. awesomepennystocker.com, nor any of its affiliates are not registered investment advisors or broker dealers.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)